| Financial Year |
March 31 2023 |
| Monetary Funds |
1,313,365,677.50 |
| Held-for-trading Financial Assets |
230,000,000.00 |
| Notes Receivable |
230,353,519.58 |
| Accounts Receivable |
619,896,782.33 |
| Advances to Suppliers |
42,376,500.58 |
| Other Receivables |
34,812,972.98 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
4,844,403.20 |
| Inventories |
504,417,206.32 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,727,119.30 |
| Total Current Assets |
3,108,286,084.42 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
20,486,607.51 |
| Investment Properties |
-- |
| Fixed Assetes |
990,422,379.02 |
| Under-construction Projects |
65,345,700.14 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
314,485,003.00 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
275,808.47 |
| Deferred Income Tax Assets |
39,077,219.22 |
| Other Non-Current Assets |
5,700,327.69 |
| Sub-Total of Non-Current Assets |
1,509,932,368.39 |
| Total Assets |
4,618,218,452.81 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
342,538,510.26 |
| Accounts Payable |
643,340,001.52 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
95,135,086.75 |
| Taxes Payable |
6,596,592.84 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
107,943,531.17 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,177,009.10 |
| Other Current Liabilities |
151,406,859.74 |
| Sub-Total of Current Liabilities |
1,436,311,126.01 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
8,531,538.10 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
138,516,948.43 |
| Total Liabilities |
1,574,828,074.44 |
| Paid-In Capital(Or Share Stock) |
549,034,794.00 |
| Capital Surplus |
1,115,256,128.70 |
| Surplus Reserve |
61,487,094.58 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,127,091,384.93 |
| Minority Stockholder's Interest |
179,988,631.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,863,401,746.72 |
| Owner's Equity（Stockholder's Equity） |
3,043,390,378.37 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,618,218,452.81 |
